X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11912) 11912
Publication (1369) 1369
Book Review (1139) 1139
Book Chapter (31) 31
Conference Proceeding (19) 19
Book / eBook (11) 11
Magazine Article (7) 7
Reference (6) 6
Dissertation (5) 5
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11375) 11375
animals (10304) 10304
male (7684) 7684
neurosciences (7231) 7231
rats (7079) 7079
excitatory amino acid antagonists - pharmacology (5410) 5410
rats, sprague-dawley (3478) 3478
pharmacology & pharmacy (3022) 3022
glutamate (2927) 2927
dose-response relationship, drug (2333) 2333
humans (2306) 2306
mice (2226) 2226
receptors, n-methyl-d-aspartate - antagonists & inhibitors (2179) 2179
female (2096) 2096
rats, wistar (2005) 2005
dizocilpine maleate - pharmacology (1872) 1872
neurons (1582) 1582
brain (1518) 1518
neurons - drug effects (1507) 1507
excitatory amino-acids (1436) 1436
rat (1412) 1412
psychiatry (1411) 1411
excitatory amino acid agonists - pharmacology (1399) 1399
methyl aspartate (1333) 1333
disease models, animal (1263) 1263
excitatory amino acid antagonists - administration & dosage (1249) 1249
time factors (1218) 1218
receptors, n-methyl-d-aspartate - metabolism (1217) 1217
clinical neurology (1115) 1115
excitatory amino acid antagonists - therapeutic use (1112) 1112
glutamic acid - metabolism (1080) 1080
behavior, animal - drug effects (1040) 1040
nmda (1037) 1037
neurology (1021) 1021
nmda receptor (989) 989
schizophrenia (977) 977
long-term potentiation (976) 976
mk-801 (954) 954
motor activity - drug effects (951) 951
hippocampus (941) 941
methyl-d-aspartate (920) 920
hippocampus - drug effects (914) 914
in vitro techniques (873) 873
article (861) 861
receptors, n-methyl-d-aspartate - physiology (841) 841
analysis of variance (820) 820
ketamine (810) 810
n-methylaspartate - pharmacology (809) 809
nmda receptors (776) 776
dopamine (773) 773
neurons - metabolism (767) 767
analysis (737) 737
physiology (720) 720
neurons - physiology (710) 710
synaptic transmission - drug effects (710) 710
brain - drug effects (707) 707
drug interactions (690) 690
biochemistry & molecular biology (671) 671
rodents (671) 671
behavioral sciences (667) 667
prefrontal cortex (659) 659
rat-brain (653) 653
nervous system (635) 635
gaba (633) 633
mice, inbred c57bl (631) 631
receptors (618) 618
animals, newborn (613) 613
microdialysis (612) 612
nucleus-accumbens (599) 599
quinoxalines - pharmacology (599) 599
2-amino-5-phosphonovalerate - pharmacology (596) 596
adult (595) 595
excitatory postsynaptic potentials - drug effects (594) 594
brain - metabolism (586) 586
ketamine - pharmacology (583) 583
cells, cultured (581) 581
central-nervous-system (578) 578
electric stimulation (575) 575
expression (574) 574
in-vivo (571) 571
synaptic transmission - physiology (570) 570
neuroprotective agents - pharmacology (557) 557
receptors, n-methyl-d-aspartate - drug effects (557) 557
hippocampus - metabolism (547) 547
physiological aspects (534) 534
microinjections (525) 525
biomedicine (519) 519
enzyme inhibitors - pharmacology (514) 514
activation (511) 511
excitotoxicity (510) 510
excitatory amino acids (505) 505
memory (497) 497
phencyclidine (497) 497
excitatory amino acid (491) 491
synaptic plasticity (489) 489
electrophysiology (486) 486
immunohistochemistry (478) 478
in-vitro (476) 476
aspartate (466) 466
dopamine - metabolism (455) 455
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11845) 11845
Russian (30) 30
Japanese (17) 17
German (15) 15
French (11) 11
Spanish (11) 11
Chinese (5) 5
Ukrainian (3) 3
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Italian (1) 1
Lithuanian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychological Medicine, ISSN 0033-2917, 05/2016, Volume 46, Issue 7, pp. 1459 - 1472
Background. Ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists (NMDAR antagonists) recently demonstrated antidepressant efficacy for the... 
depression | meta-analyses | ketamine | Bipolar depression | N-methyl-d-aspartate receptor antagonists | trajectories | TREATMENT-RESISTANT DEPRESSION | PSYCHIATRY | ADD-ON TRIAL | RANDOMIZED CONTROLLED-TRIAL | MAJOR DEPRESSION | IV KETAMINE | PSYCHOLOGY, CLINICAL | PSYCHOLOGY | PROOF-OF-CONCEPT | INTRAVENOUS KETAMINE | N-methyl-D-aspartate receptor antagonists | ANTIDEPRESSANT EFFICACY | CHANNEL BLOCKER | RATING-SCALE | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Excitatory Amino Acid Antagonists - administration & dosage | Excitatory Amino Acid Antagonists - pharmacology | Bipolar Disorder - drug therapy | Ketamine - administration & dosage | Ketamine - adverse effects | Outcome Assessment (Health Care) - statistics & numerical data | Ketamine - pharmacokinetics | Antidepressive Agents - administration & dosage | Antidepressive Agents - pharmacology | Antidepressive Agents - adverse effects | Antidepressive Agents - pharmacokinetics | Ketamine - pharmacology | Excitatory Amino Acid Antagonists - adverse effects | Depressive Disorder, Major - drug therapy | Discontinued | Depressive personality disorders | Intravenous administration | Toxicity | Clinical trials | Glutamic acid receptors | Mental depression | Dosage | Clinical outcomes | Randomized controlled trials | Confidence intervals | Psychotropic drugs | Hostility | Remission | Safety | Antidepressant drugs | Bipolar affective disorder | Efficacy | Depression | N-Methyl-D-aspartic acid receptors | Meta-analysis | Refractory depression | Side effects | Ketamine | Psychopharmacology | Superiority | Index Medicus
Journal Article
JAMA Psychiatry, ISSN 2168-622X, 06/2014, Volume 71, Issue 6, pp. 681 - 688
Journal Article
Journal of Clinical Psychopharmacology, ISSN 0271-0749, 12/2008, Volume 28, Issue 6, pp. 631 - 637
Journal Article
Journal Article
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 2009, Volume 202, Issue 2, pp. 238 - 244
Journal Article
Journal Article
Journal Article
Psychological Medicine, ISSN 0033-2917, 12/2015, Volume 45, Issue 16, pp. 3571 - 3580
Background. Suicide is a devastating public health problem and very few biological treatments have been found to be effective for quickly reducing the... 
treatment | Depression | ketamine | glutamate | suicide | NMDA RECEPTOR | PSYCHIATRY | PREVENTION | RISK | D-ASPARTATE ANTAGONIST | MAJOR DEPRESSION | PSYCHOLOGY, CLINICAL | PSYCHOLOGY | TRANSMISSION | ANTIDEPRESSANT EFFICACY | EXPRESSION | BRIEF SELF-REPORT | TRACKING SCALE | Excitatory Amino Acid Antagonists - therapeutic use | Double-Blind Method | Humans | Middle Aged | Stress Disorders, Post-Traumatic - epidemiology | Excitatory Amino Acid Antagonists - administration & dosage | Male | Suicidal Ideation | Treatment Outcome | Depressive Disorder, Major - epidemiology | Ketamine - administration & dosage | Depression - drug therapy | Psychiatric Status Rating Scales | Adult | Female | Ketamine - therapeutic use | Bipolar Disorder - epidemiology | Glutamic acid receptors (ionotropic) | Health problems | Clinical trials | Glutamic acid receptors | Suicidal ideation | Suicide | Clinical outcomes | Psychotropic drugs | Risk assessment | Suicides & suicide attempts | Hostility | Anxiety | Safety | Dropping out | Public health | Ideation | Anxiety-Depression | N-Methyl-D-aspartic acid receptors | Severity | Risk behaviour | Patients | Ketamine | Mood | Psychopharmacology | Midazolam | Suicidal behaviour | Index Medicus | Depressive Disorders | Comorbidity | Drug Therapy | Hallucinogenic Drugs | Randomized Clinical Trial | PTSD | Bipolar Disorders | Anxiety Disorders | Treatment Effectiveness | Suicidality | Borderline Personality Disorder | Adults | Negative Therapeutic Reaction
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 06/2012, Volume 15, Issue 5, pp. 657 - 668
A single non-anaesthetic dose of ketamine, a non-competitive NMDA receptor (NMDAR) antagonist with hallucinogenic properties, induces cognitive impairment and... 
Antipsychotic | schizophrenia | ketamine | gamma power | EEG | NEURONAL-ACTIVITY | NMDA RECEPTOR | GLUTAMATE-RECEPTOR AGONIST | RAT | 40 HZ | SYNCHRONY | PSYCHIATRY | NEUROSCIENCES | PREFRONTAL CORTEX | CLINICAL NEUROLOGY | PHARMACOLOGY & PHARMACY | OSCILLATIONS | 1ST-EPISODE PSYCHOSIS | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Drug Administration Schedule | Rats, Wistar | Clozapine - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Haloperidol - administration & dosage | Rats | Male | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Electrodes, Implanted | Excitatory Amino Acid Antagonists - pharmacology | Amino Acids - administration & dosage | Amino Acids - pharmacology | Ketamine - administration & dosage | Antipsychotic Agents - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Brain Waves - drug effects | Antipsychotic Agents - pharmacology | Cerebral Cortex - drug effects | Ketamine - pharmacology | Haloperidol - pharmacology | Clozapine - pharmacokinetics | Index Medicus | Drugs | Animal models | Neuroleptics | Channel gating | Glutamic acid receptors (ionotropic) | Cognitive ability | Cortex | Oscillations | Schizophrenia | Auditory evoked potentials | N-Methyl-D-aspartic acid receptors | Glutamic acid receptors | Haloperidol | Electrodes | Psychosis | Ketamine | Skull | Locomotor activity | Brain Waves | Neurons and Cognition | Receptors, N-Methyl-D-Aspartate | Cerebral Cortex | Clozapine | Amino Acids | Bicyclo Compounds, Heterocyclic | Life Sciences | Antipsychotic Agents | Excitatory Amino Acid Antagonists
Journal Article